Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Wajeeh Khan

FORGOTTEN HISTORY: A 2 billion reason why astrazeneca stock is down today | History Defined

AstraZeneca (AZN) stock came under pressure on Sept. 29 after the pharma giant announced a massive $2 billion investment in Summit Therapeutics (SMMT). As investors responded to the disclosure, AZN was briefly seen trading below its 20-day and 50-day moving averages (MAs), indicating bears are attempting to regain control in the near term.

Versus the start of 2026, AstraZeneca shares are down nearly 10% at the time of writing.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.